Overbought Stock
Report Date: 03-11-2024
Symbol: VINC - Vincerx Pharma, Inc.
Sector:
Industry:
Overbought Stock Signal: VINC
Vincerx Pharma, Inc. (VINC)
260 Sheridan Avenue
Palo Alto, CA
Phone: 650 800 6676
Website: http://www.vincerx.com
CEO: Dr. Ahmed M. Hamdy
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincerx Pharma, Inc. is based in Palo Alto, California.